The World Bank Implementation Status & Results Report Tunisia COVID-19 Response project (P173945) Tunisia COVID-19 Response project (P173945) MIDDLE EAST AND NORTH AFRICA | Tunisia | Health, Nutrition & Population Global Practice | IBRD/IDA | Investment Project Financing | FY 2020 | Seq No: 2 | ARCHIVED on 25-Mar-2021 | ISR45379 | Implementing Agencies: Republic of Tunisia, Ministry of Health Key Dates Key Project Dates Bank Approval Date: 30-Apr-2020 Effectiveness Date: 01-Jun-2020 Planned Mid Term Review Date: 20-Apr-2022 Actual Mid-Term Review Date: Original Closing Date: 30-Jun-2021 Revised Closing Date: 30-Jun-2021 pdoTable Project Development Objectives Project Development Objective (from Project Appraisal Document) To improve COVID-19 detection and infection control in Tunisia through increasing the availability of COVID-19 equipment and supplies. Has the Project Development Objective been changed since Board Approval of the Project Objective? No Components Table Name Emergency COVID-19 Response:(Cost $19.85 M) Implementation Management and Monitoring and Evaluation:(Cost $0.10 M) Overall Ratings Name Previous Rating Current Rating Progress towards achievement of PDO Satisfactory Satisfactory Overall Implementation Progress (IP) Satisfactory Satisfactory Overall Risk Rating Moderate Moderate Implementation Status and Key Decisions The project was approved by the World Bank's Executive Board on April 30, 2020 and was declared effective on June 1st, 2020. The project is financed by a US$20 million loan under the Multiphase Programmatic Approach supported by the Fast Track COVID-19 Facility. The project will be implemented over 13 months until June 30, 2021. The disbursement rate is 100 percent, with US$20 million fully disbursed through an advance to purchase goods and services for COVID-19 response in Tunisia. MPA Program Development Objective MPA PDO Table 3/25/2021 Page 1 of 5 The World Bank Implementation Status & Results Report Tunisia COVID-19 Response project (P173945) The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness MPA Table Multiphase Programmatic Approach (MPA) Status MPA Table Body The implementation of the MPA-funded projects continues to progress well. As of March 15, 2021, 86 MPA-projects have been approved providing a total commitment of US$4.20 billion. Disbursements have continued to increase at a rapid pace. Thirty four (34) country projects or 40% of projects approved have reached 70-100% disbursements. The projects benefit around 3.7 billion people or 50% of the global population. Of the 86 approved projects: (i) 33 are in Africa – 12 in AFE and 21 in AFW; (ii) 12 in East Asia; (iii) 13 in Europe and Central Asia; (iv) 12 in Latin America and the Caribbean; (v) 7 in Middle East and North Africa; and (vi) 9 in South Asia. Seventy two (72) projects are disbursing. Total disbursements as of March 15, 2021 under these projects amount to US$2,139.8 million or 51% of overall commitments. In addition, $641 million have been committed under signed contracts with UNICEF and Bank Facilitated Procurement. Streamlined procedures, delegated approval coupled with flexible project design and intensified efforts across the Bank have contributed to the progress. Several projects have/are being restructured to include vaccine related procurement. Implementation continues to face challenges as some countries are still under different levels of lockdown or mobility restrictions and counterparts and Bank teams are operating from home. Bank teams continue to conduct implementation support missions virtually, which is challenging for both Bank teams and counterparts. This creates connectivity challenges as internet is not reliable in many of the IDA countries. Notwithstanding challenges, the MPA is on track to achieving its PDO – to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness. The significant level of disbursements in just over eleven months attest to the strong implementation of the Bank response thanks to the commitment of counterparts supported by country teams. Risks Systematic Operations Risk-rating Tool Risk Category Rating at Approval Previous Rating Current Rating Political and Governance Moderate Moderate Moderate Macroeconomic Substantial Substantial Substantial Sector Strategies and Policies Moderate Moderate Moderate Technical Design of Project or Program Moderate Moderate Moderate Institutional Capacity for Implementation and Substantial Substantial Substantial Sustainability Fiduciary Substantial Substantial Substantial Environment and Social Moderate Moderate Moderate Stakeholders Moderate Moderate Moderate Other -- -- -- Overall Moderate Moderate Moderate Results 3/25/2021 Page 2 of 5 The World Bank Implementation Status & Results Report Tunisia COVID-19 Response project (P173945) PDO Indicators by Objectives / Outcomes To improve COVID-19 detection and infection control by increasing the availability of equipment IN00950257 ►Number of health facilities and laboratories provided with personal protective equipment under the project (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 263.00 228.00 Date 30-Apr-2020 16-Jul-2020 03-Feb-2021 30-Jun-2021 IN00950258 ►Number of tests conducted for COVID-19 using Polymerase Chain Reaction (PCR) machines (Number, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 17,558.00 17,588.00 766,397.00 600,000.00 Date 27-Apr-2020 16-Jul-2020 03-Feb-2021 30-Jun-2021 Intermediate Results Indicators by Components Emergency COVID-19 response IN00950259 ►Percentage of Project supported health facilities and laboratories confirming receipt of equipment within 14 days of in-country delivery of such equipment (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 100.00 100.00 Date 30-Apr-2020 16-Jul-2020 03-Feb-2021 30-Jun-2021 Implementation Management and Monitoring and Evaluation IN00950260 ►Percentage of sampled Project supported health facilities and laboratories that have received equipment verified for installation and functionality (Percentage, Custom) Baseline Actual (Previous) Actual (Current) End Target Value 0.00 0.00 0.00 100.00 Date 30-Apr-2020 16-Jul-2020 16-Jul-2020 30-Jun-2021 Performance-Based Conditions Data on Financial Performance 3/25/2021 Page 3 of 5 The World Bank Implementation Status & Results Report Tunisia COVID-19 Response project (P173945) Disbursements (by loan) Project Loan/Credit/TF Status Currency Original Revised Cancelled Disbursed Undisbursed % Disbursed P173945 IBRD-91120 Effective USD 20.00 20.00 0.00 20.52 0.00 100% Key Dates (by loan) Project Loan/Credit/TF Status Approval Date Signing Date Effectiveness Date Orig. Closing Date Rev. Closing Date P173945 IBRD-91120 Effective 30-Apr-2020 11-May-2020 01-Jun-2020 30-Jun-2021 30-Jun-2021 Cumulative Disbursements PBC Disbursement Achievement Disbursed amount in Disbursement % PBC ID PBC Type Description Coc PBC Amount Status Coc for PBC 3/25/2021 Page 4 of 5 The World Bank Implementation Status & Results Report Tunisia COVID-19 Response project (P173945) Restructuring History There has been no restructuring to date. Related Project(s) P175785-Additional Financing for Tunisia COVID-19 Response Project 3/25/2021 Page 5 of 5